Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts

To Adjust or Not to Adjust? When a “Confounder” Is Only Measured After Exposure

(2021) Rolf H. H. Groenwold et al.   EPIDEMIOLOGY

Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's Disease

(2020) Carlo Wilke et al.   MOVEMENT DISORDERS

CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories

(2020) Stefanie Lerche et al.   MOVEMENT DISORDERS

Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease

(2020) Frederic Sampedro et al.   PARKINSONISM & RELATED DISORDERS

Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson’s disease

(2020) Adeline Su Lyn Ng et al.   Molecular Neurodegeneration

Is There a Value of Neurofilament Light as a Biomarker for Neurodegeneration in Parkinson's Disease?

(2020) Henrik Zetterberg   MOVEMENT DISORDERS

Serum neurofilament light as a biomarker in progressive multiple sclerosis

(2020) Raju Kapoor et al.   NEUROLOGY

Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology

(2020) Huei-Chun Liu et al.   PLoS One

Acute Neurofilament Light Chain Plasma Levels Correlate With Stroke Severity and Clinical Outcome in Ischemic Stroke Patients

(2020) Helle H. Nielsen et al.   Frontiers in Neurology

Current and projected future economic burden of Parkinson’s disease in the U.S.

(2020) Wenya Yang et al.   npj Parkinsons Disease

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression

(2020) Brit Mollenhauer et al.   MOVEMENT DISORDERS

CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression

(2020) Qionghua Sun et al.   Frontiers in Neurology

Equivalence of serum and plasma neurofilament light chain levels using highly sensitive automated immunoassay

(2020) Xiaolei Qiu et al.   Alzheimers & Dementia

Serum NFL discriminates Parkinson disease from atypical parkinsonisms

(2019) Tainá M. Marques et al.   NEUROLOGY

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

(2019) Claire Bridel et al.   JAMA Neurology

Blood NfL

(2019) Chin-Hsien Lin et al.   NEUROLOGY

CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls

(2019) Linda P. Oosterveld et al.   MOVEMENT DISORDERS

Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson’s Disease

(2019) Chih-Hao Chen et al.   Journal of Parkinsons Disease

Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors

(2018) Fatemeh N. Emamzadeh et al.   Frontiers in Neuroscience

Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2018) E. Ray Dorsey et al.   LANCET NEUROLOGY

Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease

(2018) Yung-Shuan Lin et al.   Scientific Reports

Blood-based NfL

(2017) Oskar Hansson et al.   NEUROLOGY

Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases

(2017) Michael G. Erkkinen et al.   Cold Spring Harbor Perspectives in Biology

Parkinson disease

(2017) Werner Poewe et al.   Nature Reviews Disease Primers

Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB)

(2016) Carl E Clarke et al.   HEALTH TECHNOLOGY ASSESSMENT

Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta

(2016) Jason Langley et al.   MOVEMENT DISORDERS

Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With123I-FP-CIT SPECT

(2016) Yun Jung Bae et al.   MOVEMENT DISORDERS

The Impact of DaTscan in the Diagnosis of Parkinson Disease

(2015) Isis Gayed et al.   CLINICAL NUCLEAR MEDICINE

Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease

(2015) Gabriel Castellanos et al.   MOVEMENT DISORDERS

Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice

(2015) Fang Ba et al.   PARKINSONISM & RELATED DISORDERS

The ‘Swallow Tail’ Appearance of the Healthy Nigrosome – A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3T

(2014) Stefan T. Schwarz et al.   PLoS One

A comparison of confounding adjustment methods with an application to early life determinants of childhood obesity

(2014) L. Li et al.   Journal of Developmental Origins of Health and Disease